What is the role of GB virus C infection in hepatitis C virus/HIV coinfection?

Journal of Infectious Diseases

Volumn 194, Issue 4, 2006, Pages 407-409

  Berzsenyi, Mark D ^a   Roberts, Stuart K ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTERFERON; PEGINTERFERON; RIBAVIRIN;

CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS G; HEPATITIS G VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION;

GB VIRUS C; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS;

EID: 33746725307     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/505716     Document Type: Editorial

References (25)

1. Heringlake S, Ockenga J, Tillmann HL, et al. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 1998; 177:1723-6.
2. Lefrère J-J, Roudot-Thoraval F, Morand-Joubert L, et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 1999; 179:783-9.
3. Yeo AE, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study. Ann Intern Med 2000; 132:959-63.
4. Tillmann HL, Heiken H, Knapik-Botor A, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001; 345:715-24.
5. Xiang J, Wunschmann S, Diekema DJ, et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 2001; 345:707-14.
6. Williams CF, Klinzman D, Yamashita TE, et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 2004; 350:981-90.
7. Berzsenyi MD, Bowden DS, Roberts SK. GB virus C: insights into co-infection. J Clin Virol 2005; 33:257-66.
8. Birk M, Lindback S, Lidman C. No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients. AIDS 2002; 16:2482-5.
9. Brumme ZL, Chan KJ, Dong WW, et al. No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy. AIDS 2002; 16:1929-33.
10. Bjorkman P, Flamholc L, Naucler A, Molnegren V, Wallmark E, Widell A. GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS 2004; 18:877-86.
11. Van der Bij AK, Kloosterboer N, Prins M, et al. GB virus C coinfection and HIV-1 disease progression: the Amsterdam Cohort Study. J Infect Dis 2005; 191:678-85.
12. Oshita M, Hayashi N, Mita E, et al. GBV-C/HGV infection in chronic hepatitis C patients: its effect on clinical features and interferon therapy. J Med Virol 1998; 55:98-102.
13. Yu ML, Chuang WL, Dai CY, et al. GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-alpha therapy. Antiviral Res 2001; 52:241-9.
14. Rambusch EG, Wedemeyer H, Tillmann HL, Heringlake S, Manns MP, Significance of coinfection with hepatitis G virus for chronic hepatitis C-a review of the literature [in German]. Z Gastroenterol 1998; 36:41-53.
15. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999; 30:1054-8.
16. Voirin N, Trepo C, Esteve J, et al. Effects of co-infection with hepatitis C virus and GB virus C on CD4 cell count and HIV-RNA level among HIV-infected patients treated with highly active antiretroviral therapy. AIDS 2002; 16:1556-9.
17. Schwarze-Zander C, Blackard JT, Zheng H, et al. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected persons receiving HCV treatment: importance of GBV-C genotype. J Infect Dis 2006; 194:410-9 (in this issue).
18. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358:958-65.
19. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004; 351:438-50.
20. Smith DB, Basaras M, Frost S, et al. Phylogenetic analysis of GBV-C/hepatitis G virus. J Gen Virol 2000; 81:769-80.
21. Muerhoff AS, Tillmann HL, Manns MP, Dawson GJ, Desai SM. GB virus C genotype determination in GB virus-C/HIV co-infected individuals. J Med Virol 2003; 70:141-9.
22. George SL, Xiang J, Stapleton JT. Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. Virology 2003; 316:191-201.
23. Tacke M, Kiyosawa K, Stark K, et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997; 349:318-20.
24. Tacke M, Schmolke S, Schlueter V, et al. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 1997; 26:1626-33.
25. Bollinger RC, Gupta A. GB virus type C: a virus in search of a disease or a role in HIV therapy? Clin Infect Dis 2004; 38:410-1.